COMPASS FINANCIAL MANAGEMENT LLC’s Immix Biopharma IMMX Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56K	Buy	+6,000	New	+$55.7K	0.01%	671

Other funds holding IMMX

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LFM

LGT Fund Management Vaduz, Liechtenstein $2.4B AUM 38.22% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's IMMX Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Immix Biopharma (IMMX) in Q2 2026: 6,000 shares worth $56K. The stake represents 0.01% of the portfolio and ranks #671 among its holdings.

50 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 6,000 shares of Immix Biopharma worth $56K as of Q2 2026.
Immix Biopharma was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Immix Biopharma made up 0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #671 holding.
50 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.